HALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INC

HALOZYME THERAPEUTICS INC

No trades
See on Supercharts

Price target

59.780.000.00%
The 8 analysts offering 1 year price forecasts for 1HALO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to 1HALO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1HALO EPS for the last quarter is 1.22 EUR despite the estimation of 1.12 EUR. In the next quarter EPS is expected to reach 0.85 EUR. Track more of HALOZYME THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter HALOZYME THERAPEUTICS INC revenue is expected to reach ‪212.70 M‬ EUR. Check out HALOZYME THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, 1HALO price target is 59.78 EUR with a max estimate of 69.10 EUR and a min estimate of 51.39 EUR. Check if this forecast comes true in a year, meanwhile watch HALOZYME THERAPEUTICS INC stock price chart and keep track of the current situation with 1HALO news and stock market news.
We've gathered opinions of 9 analysts rating 1HALO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.